# Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients

> **NCT03173820** · NA · UNKNOWN · sponsor: **Khon Kaen University** · enrollment: 120 (estimated)

## Conditions studied

- Kidney Transplantation

## Interventions

- **GENETIC:** Genotype guided
- **GENETIC:** Conventional

## Key facts

- **NCT ID:** NCT03173820
- **Lead sponsor:** Khon Kaen University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04-30
- **Primary completion:** 2017-12-31
- **Final completion:** 2018-06-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2017-06-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03173820

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03173820, "Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03173820. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*